Genetics of long QT syndrome

David J Tester1, Michael J Ackerman1

  • 1Mayo Clinic, Rochester, Minnesota.

Insights

Long QT syndrome (LQTS) is a genetic heart condition causing delayed repolarization and increased risk of sudden cardiac death. Genetic testing is crucial but requires careful interpretation of genotype-phenotype correlations.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Long QT syndrome (LQTS) is a life-threatening cardiac arrhythmia linked to delayed myocardial repolarization.
  • It increases the risk of torsades des pointes (TdP), syncope, seizures, and sudden cardiac death (SCD).
  • Three major genes (KCNQ1, KCNH2, SCN5A) cause ~75% of LQTS cases, with minor genes accounting for <5%.

Purpose of the Study:

  • To review genotype-phenotype correlations in LQTS.
  • To discuss risk stratification based on specific mutations.
  • To highlight the importance of careful interpretation of genetic testing results.

Main Methods:

  • Review of current literature on LQTS genetics and clinical manifestations.
  • Analysis of genotype-phenotype correlations for major and minor LQTS genes.
  • Discussion of atypical LQTS and syndromic disorders associated with QT prolongation.

Main Results:

  • Major LQTS genotypes show gene-specific triggers, ECG patterns, and therapeutic responses.
  • Intragenic and mutation-specific risk stratification is increasingly feasible.
  • Atypical LQTS syndromes include ankyrin-B, Anderson-Tawil (ATS), and Timothy syndrome (TS).

Conclusions:

  • Genetic testing is recommended for suspected or persistent QT prolongation.
  • Understanding genotype-phenotype correlations aids in risk stratification and management.
  • Careful interpretation of genetic test results is essential for optimal patient care.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
157
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
137
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
18.8K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
2.0K
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
189